Pamela Stephenson joined Albireo in March 2019 as Chief Commercial Officer. Pamela has more than 20 years of biopharma commercial leadership experience across multiple functions and disease areas. Before joining Albireo, she served as Vice President, Global Market Access and Value, at Vertex Pharmaceuticals, where she led the global market access and pricing strategy for current and future products. Earlier in her tenure at Vertex, she led marketing and sales activities for the company’s hepatitis C and cystic fibrosis lines of business, and oversaw the U.S. launches of Incivek® (telaprevir) and Orkambi®(lumacaftor/ivacaftor). Prior to Vertex, Pamela spent 10 years at Pfizer in marketing roles of increasing responsibility for brands such as Viagra® (sildenafil citrate), Lyrica® (pregabalin), and Aromasin® (exemestane). She holds a bachelor’s degree from Brown University and received her master’s degree in public health from Boston University School of Public Health.